Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PCVX
#848
Vaxcyte, Inc. Common Stock
61.740
0
+3.31%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+3.31%
Monthly Change
+13.62%
6 month change
+45.96%
Year Change
+45.96%
Previous Close
59.760
0
Open
61.740
0
Bid
Ask
Low
61.740
0
High
61.740
0
Volume
145
Markets
US Stock Market
Healthcare
PCVX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
51.33 M
56.31 M
80.03 M
108.41 M
128.76 M
143.92 M
—
Valuation ratios
Enterprise value
977.58 M
1.27 B
2.94 B
6.43 B
10.15 B
6.47 B
19.34 B
Price to earnings ratio
—
—
-13.72
-15.2
-21.54
-8.2
-33.01
Price to sales ratio
—
—
2 022.62
3 223.57
2 282.67
—
—
Price to cash flow ratio
—
—
17.95
20.6
22.06
9.58
37.94
Price to book ratio
—
—
3.21
4.93
3.02
2.34
3.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.23
0.31
0.22
0.29
0.13
0.26
0.24
Return on equity %
0.26
0.35
0.23
0.32
0.14
0.29
0.26
Return on invested capital %
2 091.55
843.77
—
810.68
210.08
226.32
227.97
Gross margin %
100
100
100
100
100
—
—
Operating margin %
3 810.34
6 211.5
15.34 K
24.67 K
13.02 K
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
3 794.85
5 996.23
14.76 K
21.21 K
10.6 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.3
8.93
23.26
7.54
12.75
7.91
45.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.63
3.05
3.71
4.82
4.82
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
14.36
11.12
14.32
11.47
48.57
Net current asset value per share
—
—
14.53
11.28
14.66
11.96
50.2
Tangible book value per share
—
—
14.7
12.77
27.1
19.73
87.13
Working capital per share
—
—
13.9
9.78
13.51
10.45
45.37
Book value per share
—
—
14.7
12.77
27.1
19.73
87.13
News
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Vaxcyte closes $632.5 million public offering of common stock
Vaxcyte prices $550 million public offering of common stock
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Vaxcyte launches $500 million public offering of common stock
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
Cantor Fitzgerald reiterates Overweight rating on Vaxcyte stock
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Vaxcyte (NASDAQ:PCVX)
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes